The Jurong Island facility for the manufacture of enoxaparin sodium was opened in July 1999. Aventis commissioned the plant to...
Read moreDainippon Sumitomo Pharma (DSP) opened a new chemistry research building in Osaka, Japan, in June 2013. The research facility is...
Read moreDeveloped by Alizyme, a specialist biopharmaceutical company in collaboration with Takeda Pharmaceutical, cetilistat (ATL-962) is an experimental treatment for obesity....
Read moreLipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of hypertriglyceridemia in Type II diabetics....
Read moreHalaven is a non-taxane drug developed by Eisai Co. for the treatment of metastatic breast cancer. In March 2010, Eisai...
Read moreBayer Yakuhin has tendered a new application in Japan for marketing authorisation for its aflibercept solution for injection in the...
Read moreJinan Asia Pharmaceutical (JAP) opened an office in Irvine, California and introduced the newly formed HL-Pharma USA Corporation. JAP is...
Read moreWockhardt Limited, an Indian pharmaceutical and biotech firm, might be a good acquisition target amidst the rising trend of mergers...
Read morePharmaceutical companies in India are seeking larger product-liability insurance cover as they face an increase in compliance costs due to...
Read moreTasly Holding Group, a leading pharmaceutical company in China, officially launched its North American operations in the state of Maryland...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
